Protective effect of KBT-3022, a new cyclooxygenase inhibitor, in cerebral hypoxia and ischemia.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Japanese Journal of Pharmacology

• Publication date

  1995-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1254/JJP.69.421PMID 8786646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of prostaglandin synthesis in rat brain.

  2009cited by this paper
• Acute and chronic anti-inflammatory properties of [2,2-dimethyl-6-(4- chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid.

  1995cited by this paper
• The Effects of KBT-3022, a New Anti-platelet Agent, on Hemorheological Properties in Guinea Pigs

  1995cited by this paper
• Anti-thrombotic activity of KBT-3022 in experimental models of thrombosis.

  1995cited by this paper
• Absorption, Distribution and Excretion of a New Antiplatelet Drug, Ethyl 2-[4, 5-bis (4-methoxyphenyl) thiazol-2-yl]pyrrol-1-ylacetate, (KBT-3022), after Single Oral Administration in Mice

  1994cited by this paper
• Differential vulnerability in the hindbrain neurons and local cerebral blood flow during bilateral vertebral occlusion in gerbils.

  1993cited by this paper
• Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs.

  1992cited by this paper
• Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage

  1990cited by this paper
• Anti-platelet effect and mode of action of a new anti-platelet agent KBT-3022

  1990cited by this paper
• Role of arachidonic acid metabolism on ischemic brain edema and metabolism.

  1990cited by this paper
• Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia.

  1990cited by this paper
• Role for gamma-aminobutyric acid in selective vulnerability in gerbils.

  1989cited by this paper
• NSAID and gastropathy: a rheumatologist's review.

  1988cited by this paper
• Indomethacin ameliorates ischemic neuronal damage in the gerbil hippocampal CA1 sector.

  1988cited by this paper
• Immunohistochemical investigation of ischemic and postischemic damage after bilateral carotid occlusion in gerbils.

  1988cited by this paper
• Acidosis and ischemic brain damage.

  1988cited by this paper
• Glutamate and the pathophysiology of hypoxic–ischemic brain damage

  1986cited by this paper
• Thromboxane, prostacyclin, and leukotrienes in cerebral ischemia

  1986cited by this paper
• Oxygen-derived free radicals in postischemic tissue injury.

  1985cited by this paper
• Evidence for amelioration of ischaemic neuronal damage in the hippocampal formation by lesions of the perforant path.

  1985cited by this paper
• Modulatory effects of prostaglandin D2, E2 and F2 alpha on the postsynaptic actions of inhibitory and excitatory amino acids in cerebellar Purkinje cell dendrites in vitro.

  1985cited by this paper
• Free radical damage of the brain following ischemia.

  1985cited by this paper
• Effect of the Calcium Antagonist Nimodipine on Local Cerebral Blood Flow and Metabolic Coupling

  1985cited by this paper
• Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

  1984cited by this paper
• Brain injury, edema, and vascular permeability changes induced by oxygen‐derived free radicals

  1984cited by this paper
• Anti-hypoxic effect of indomethacin and its interaction with prostacyclin.

  1983cited by this paper
• Ischemic brain injury: the importance of calcium, lipolytic activities, and free fatty acids.

  1982cited by this paper
• Delayed neuronal death in the gerbil hippocampus following ischemia.

  1982cited by this paper
• Temporal profile of neuronal damage in a model of transient forebrain ischemia

  1982cited by this paper
• The effect of incomplete cerebral ischemia on prostaglandin levels in rat brain.

  1982cited by this paper
• Anti-hypoxic effects of etomidate, thiopental and methohexital.

  1981cited by this paper
• Brain Lactic Acidosis and Ischemic Cell Damage: 1. Biochemistry and Neurophysiology

  1981cited by this paper
• Transient Formation of Superoxide Radicals in Polyunsaturated Fatty Acid‐Induced Brain Swelling

  1980cited by this paper
• The free radical pathology and the microcirculation in the major central nervous system disorders.

  1980cited by this paper
• Transient cerebral ischemia and brain prostaglandins.

  1979cited by this paper
• The mechanism of action of a novel cerebral protective drug against anoxia I. The effect on cerebral energy demand.

  1979cited by this paper
• Protective effect of anti-anxiety drugs against hypoxia

  1973cited by this paper
• Increased tolerance to cerebral anoxia by pentobarbital.

  1966cited by this paper
• EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.

  1964cited by this paper

• Cyclooxygenase inhibition in ischemic brain injury.

  2008cites this paper
• Increased Expression of Cyclo-Oxygenase 2 and Vascular Endothelial Growth Factor in Lesioned Spinal Cord by Transplanted Olfactory Ensheathing Cells

  2004cites this paper
• Inflammatory Mechanisms in Parkinson’s Disease

  2003cites this paper
• Differential effects of ethanol on the expression of cyclo‐oxygenase in cultured cortical astrocytes and neurons

  2001cites this paper
• Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

  2000cites this paper
• Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system.

  1999cites this paper
• Characterization of temperature rise of the brain and the rectum following intracerebroventricular administration of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate in rats.

  1998cites this paper
• Characterization of temperature rise of the brain and the rectum following intracerebroventricular administration of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate in rats

  1998cites this paper
• Inhibition of NMDA-induced increase in brain temperature by N-omega-nitro-L-arginine and indomethacin in rats.

  1997cites this paper